Breast Journal

Papers
(The TQCC of Breast Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The effects of vitamin D replacement on pathological complete response (pCR) in breast cancer patients receiving neoadjuvant systemic chemotherapy (NAC)29
Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective S24
Breast Cancer Epidemiology and Survival Analysis of Shenyang in Northeast China: A Population-Based Study from 2008 to 201720
The continued role of intraoperative assessment of the surgical margins in lumpectomy samples19
Combined Endoscopy-Assisted Muscle-Sparing Latissimus Dorsi Flap Harvesting with Lipofilling Enhancement as a New Volume Replacement Technique in Breast Reconstruction18
Survival Estimation, Prognostic Factors Evaluation, and Prognostic Prediction Nomogram Construction of Breast Cancer Patients with Bone Metastasis in the Department of Bone and Soft Tissue Tumor: A Si17
Brain Metastasis in Triple‐Negative Breast Cancer14
The effect of immediate breast reconstruction on adjuvant therapy delay, locoregional recurrence, and disease‐free survival14
Efficacy of Presurgical Short‐Term Endocrine Therapy During the Waiting Period for Surgery in Postmenopausal Hormone Receptor‐Positive Breast Cancer13
Unveiling miRNA30b’s Role in Suppressing ADAM12 to Combat Triple‐Negative Breast Cancer12
Survival Outcomes of Breast-Conserving Therapy versus Mastectomy in Early-Stage Breast Cancer, Including Centrally Located Breast Cancer: A SEER-Based Study11
Application of Microwave Ablation Combined With Chai Hu Qing Gan Tang in the Treatment of Idiopathic Granulomatous Mastitis11
9
Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy8
LncRNA FAM225B Regulates PDIA4-Mediated Ovarian Cancer Cell Invasion and Migration via Modulating Transcription Factor DDX178
Comparison of BRCA1 Gene Expression and CA15‐3 Tumor Marker Level in Different Stages of Breast Cancer7
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer Risk7
Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients6
Development of the Breast Surgical Oncology Fellowship in the United States5
Associations between Physical Exercise, Quality of Life, Psychological Symptoms and Treatment Side Effects in Early Breast Cancer5
The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience5
Clinical Radiologic Analysis of 2964 Papillary Breast Lesions5
First case report of bilateral breast necrosis following coronary artery bypass graft using left internal mammary artery5
Switching to Tumescent Dissection in Mastectomy5
Extratumoral Signs of Malignant Nonspiculate and Noncalcified Masses on Mammography: Are They Associated With Prognostic Factors in Breast Cancer?4
Patient‐ versus physician‐reported outcomes in a low‐dose tamoxifen trial in noninvasive breast cancer4
Diagnosis of Benign and Malignant Newly Developed Nodules on the Surgical Side After Breast Cancer Surgery Based on Machine Learning4
Contralateral prophylactic mastectomy in the setting of breast cancer diagnosis and their insurance coverage in the United States4
Single‐Port Three‐Dimensional Endoscopic‐Assisted Axillary Lymph Node Dissection (S‐P 3D E‐ALND): Surgical Technique and Preliminary Results4
Farewell to The Breast Journal : A novel scientific publication led by a pathologist who moved beyond the microscope and faced the patients4
NOTIFICATION: The Role of Pathologists in Recognition of Morphologic and Biologic Features of Genetically Mutated Breast Cancer4
MLLT11 siRNA Inhibits the Migration and Promotes the Apoptosis of MDA-MB-231 Breast Cancer Cells4
Role of Qualitative and Quantitative Indocyanine Green Angiography to Assess Mastectomy Skin Flaps Perfusion in Nipple/Skin-Sparing and Skin-Reducing Mastectomies with Implant-Based Breast Reconstruct4
Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers4
Catheter Tip Migration in Female Patients With Breast Cancer: A Retrospective Comparative Study of Right‐ and Left‐Sided Chest Ports4
Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2‐Positive Breast Cancer4
Duration of Breastfeeding and Risk Reduction of Breast Cancer among Mothers Who Have Ever Breastfed: A Case‐Control Study Conducted in Bahir Dar, Ethiopia3
Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study3
Causes of Unwarranted Variation and Disparity in Breast Cancer Management in Regional and Rural Area3
The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting3
NOTIFICATION: Is it Ductal Carcinoma in Situ with Microinvasion or “Ductogenesis”? The Role of Myoepithelial Cell Markers3
Minimally Invasive Excision of Breast Masses under Ultrasound Guidance: A Single Center’s Five-Year Experience on the Breast Lesion Excision System3
Factors Associated with Late Local Radiation Toxicity after Post-Operative Breast Irradiation3
3
Rare Histological Types of Breast Cancer: A Single‐Center Experience3
Bilateral breast necrotizing leukocytoclastic vasculitis: First case report3
Comparing the Prognoses of Breast-Conserving Surgeries for Differently Aged Women with Early Stage Breast Cancer: Use of a Propensity Score Method3
MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study3
The Relationship Between Clinicopathological Features and Prognosis of 22 Cases of Tubular Breast Carcinoma3
Value of Quantitative SPECT/CT Lymphoscintigraphy in Improving Sentinel Lymph Node Biopsy in Breast Cancer3
0.23711609840393